Steffann Julie, Bonnefont Jean-Paul, Frydman Nelly
Université Paris-Descartes, Institut Imagine UMR 1163, et Hôpital Necker-Enfants Malades (AP-HP), Paris, F-75015, France.
AP-HP, Biologie de la Reproduction, Université Paris-Sud, Université Paris-Saclay, Hôpital Antoine-Béclère Clamart, F-92140, France.
Med Sci (Paris). 2017 Jun-Jul;33(6-7):642-645. doi: 10.1051/medsci/20173306022. Epub 2017 Jul 19.
The recent birth from a mitochondrial DNA mutation carrier of a child, conceived after transfer in a donor oocyte of the meiotic spindle, taken from the maternal oocyte, revived the debate on the safety of these procedures. The doubts concern mainly the possibility of genetic reversion, the uncertainties about potential disturbances of the dialogue between nuclear and mitochondrial genomes and the side effects of a heteroplasmic state induced by these techniques. The possibility to expand nuclear transfer applications to patients experiencing in vitro fertilization failure, urges us to answer these questions rapidly.
最近,一名线粒体DNA突变携带者在移植了取自母体卵母细胞的减数分裂纺锤体的供体卵母细胞后生下了一个孩子,这再次引发了关于这些操作安全性的争论。疑虑主要涉及基因逆转的可能性、核基因组与线粒体基因组之间对话潜在干扰的不确定性以及这些技术诱导的异质性状态的副作用。将核移植应用扩展到体外受精失败患者的可能性,促使我们迅速回答这些问题。